These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 8750352)
1. Computer-assisted and visual methods of assessing cellular proliferation in tissue sections from non-Hodgkin's lymphoma a comparison. Hendricks JB; Rainer R; Munakata S Anal Quant Cytol Histol; 1995 Dec; 17(6):383-8. PubMed ID: 8750352 [TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of cellular proliferative activity in 35 T-cell non-Hodgkin's lymphomas. Use of proliferating cell nuclear antigen and Ki-67 (MIB-1) antibodies and nucleolar organizer regions. Caulet-Maugendre S; Patey M; Granier E; Joundi A; Gentile A; Caulet T Anal Quant Cytol Histol; 1996 Oct; 18(5):337-44. PubMed ID: 8908304 [TBL] [Abstract][Full Text] [Related]
3. Morphometric analysis of AgNORs in imprints and sections from non-Hodgkin's lymphomas. An approach to standardization. Munakata S; Hendricks JB Anal Quant Cytol Histol; 1993 Oct; 15(5):329-34. PubMed ID: 8259974 [TBL] [Abstract][Full Text] [Related]
4. Quantitative study of AgNOR in differential diagnosis between non-Hodgkin's lymphoma and reactive hyperplasia. Gan X Chin Med J (Engl); 1995 Feb; 108(2):132-7. PubMed ID: 7774388 [TBL] [Abstract][Full Text] [Related]
5. A comparison of nucleolar organizer region staining and Ki-67 immunostaining in non-Hodgkin's lymphoma. Hall PA; Crocker J; Watts A; Stansfeld AG Histopathology; 1988 Apr; 12(4):373-81. PubMed ID: 2453436 [TBL] [Abstract][Full Text] [Related]
6. Morphometric analysis of AgNORs in the lymph node lesions. Arora B; Jain R; Kumar S; Rekhi B; Arora H; Arora DR Adv Clin Path; 2002 Apr; 6(2):95-9. PubMed ID: 19753731 [TBL] [Abstract][Full Text] [Related]
7. The relation of argyrophilic proteins of nucleolar organizer regions (AgNORs) to the proportions of Ki-67 or DNA polymerase alpha-reacting cells in non-Hodgkin's lymphomas. Okabe Y; Nakamura S; Okumura H; Matano S; Kobayashi K; Ohtake S; Yoshida T; Matsuda T; Mizukami Y; Nonomura A Anticancer Res; 1991; 11(6):2031-5. PubMed ID: 1723261 [TBL] [Abstract][Full Text] [Related]
8. Prognostic utility of silver stained nucleolar organiser region counting in non Hodgkin's lymphoma. Iyer VK; Raina V; Dawar R Indian J Cancer; 2000 Dec; 37(4):140-7. PubMed ID: 12018565 [TBL] [Abstract][Full Text] [Related]
9. Correlation between DNA flow cytometric and nucleolar organizer region data in non-Hodgkin's lymphomas. Crocker J; Macartney JC; Smith PJ J Pathol; 1988 Feb; 154(2):151-6. PubMed ID: 3280766 [TBL] [Abstract][Full Text] [Related]
10. Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma. Vail DM; Kisseberth WC; Obradovich JE; Moore FM; London CA; MacEwen EG; Ritter MA Exp Hematol; 1996 Jun; 24(7):807-15. PubMed ID: 8647231 [TBL] [Abstract][Full Text] [Related]
11. Characterization of the proliferation state in canine mammary tumors by the standardized AgNOR method with postfixation and immunohistologic detection of Ki-67 and PCNA. Löhr CV; Teifke JP; Failing K; Weiss E Vet Pathol; 1997 May; 34(3):212-21. PubMed ID: 9163877 [TBL] [Abstract][Full Text] [Related]
12. Cell kinetics analysis in stage I endometrial carcinoma as determined by image cytometry and immunohistochemistry. Correlation with clinicopathologic characteristics. Miliaras D; Papaemmanuil S Anal Quant Cytol Histol; 2004 Feb; 26(1):7-14. PubMed ID: 15032075 [TBL] [Abstract][Full Text] [Related]
13. Sequential demonstration of nucleolar organizer regions and Ki67 immunolabelling in non-Hodgkin's lymphomas. Janmohamed RM; Murray PG; Crocker J; Leyland MJ Clin Lab Haematol; 1990; 12(4):395-9. PubMed ID: 2081380 [TBL] [Abstract][Full Text] [Related]
14. AgNORs predictive value of prognosis in non-Hodgkin's lymphoma according to the Kiel classification. Jakić-Razumović J; Petrovecki M; Dominis M Mod Pathol; 1995 Feb; 8(2):143-9. PubMed ID: 7777474 [TBL] [Abstract][Full Text] [Related]
15. Argyrophilic nucleolar organizer region in proliferating cell has a predictive value for local recurrence in superficial bladder tumor. Tomobe M; Shimazui T; Uchida K; Hinotsu S; Akaza H J Urol; 1999 Jul; 162(1):63-8. PubMed ID: 10379741 [TBL] [Abstract][Full Text] [Related]
16. Correlation between PCNA and AgNOR scores in non-Hodgkin's lymphomas using sequential staining technique. Smith FG; Murray PG; Crocker J J Clin Pathol; 1993 Jan; 46(1):28-31. PubMed ID: 8094401 [TBL] [Abstract][Full Text] [Related]
17. Application of the AgNOR method to cell imprints of lymphoid tissue. Boldy DA; Crocker J; Ayres JG J Pathol; 1989 Jan; 157(1):75-9. PubMed ID: 2466112 [TBL] [Abstract][Full Text] [Related]
18. Expression of argyrophilic nucleolar organizer regions (AgNORs) can be used to assess cellular proliferation as shown in rat thymic sections. Carbajo-Perez E; Alberca V; Vicente-Villardon V; Flores T; Carbajo S Histochem J; 1993 Aug; 25(8):548-53. PubMed ID: 8407364 [TBL] [Abstract][Full Text] [Related]
19. [AgNOR in the pathologic differential diagnosis of tumors]. Chen BF Zhonghua Zhong Liu Za Zhi; 1992 Nov; 13(6):463-6. PubMed ID: 1315672 [TBL] [Abstract][Full Text] [Related]
20. Quantitative AgNOR assessment of cancer cell populations in undifferentiated nasopharyngeal carcinoma. Chen M; Lee JC; Lo S Anal Quant Cytol Histol; 2002 Apr; 24(2):89-92. PubMed ID: 12026056 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]